EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation

Konstanze Diefenbach,1 Dietmar Trummer,1 Frank Ebert,1 Michael Lissy,2 Manuela Koch,2 Beate Rohde,1 Hartmut Blode3 1Bayer HealthCare Pharmaceuticals, Berlin, Germany; 2Nuvisan GmbH, Neu-Ulm, Germany; 3Bayer HealthCare Pharmaceuticals Global R&D Center, Beijing, People's Republic of China Bac...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Diefenbach K, Trummer D, Ebert F, Lissy M, Koch M, Rohde B, Blode H
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Dove Medical Press 2013-04-01
Sarja:	International Journal of Women's Health
Linkit:	http://www.dovepress.com/ee-drospirenone-levomefolate-calcium-versus-ee-drospirenone--folic-aci-a12725
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!